跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,641 条关于
“PD1-41BB”
全部
2,641
临床试验
2,021
药物
249
机构
6
资讯
365
2年前
FDA Clears IND for Medigene's TCR-T Therapy MDG1015 in Advanced Solid Tumors
去年
Medigene AG Refocuses Strategy on TCR-Guided Therapies, Pauses MDG1015 Trial
2年前
Medicenna Presents Preclinical Data on IL-2 Super-Antagonist MDNA209 and Anti-PD1-IL-2 BiSKIT MDNA113
11个月前
IL33-ST2 Axis Emerges as Predictive Biomarker for Anti-PD1 Therapy in Advanced Gastric Cancer
去年
Anti-PD1 Precision Therapy Shows Promise in Unresectable Stage III NSCLC Trial
8天前
Salk Team Maps How Chronic Interferon II Drives Immunosuppression and Anti-PD1 Resistance in Melanoma
2年前
Replimune's RP1 Shows Durable Responses in Anti-PD1 Failed Melanoma
去年
HAIC Plus Lenvatinib and PD-1 Inhibitors Improve Outcomes in Advanced Intrahepatic Cholangiocarcinoma
去年
Teva and Fosun Pharma Form Strategic Partnership for Novel Anti-PD1-IL2 Cancer Immunotherapy TEV-56278
去年
Replimune's RP1 Plus Nivolumab Shows Promise in Anti-PD1 Failed Melanoma
第 1 页,共 37 页
上一页
下一页